Evidence map›Paper›PMID 19818340›Full record

ArticleDevelopmental biology2010

Roles of the Wnt effector POP-1/TCF in the C. elegans endomesoderm specification gene network.

Melissa Owraghi, Gina Broitman-Maduro, Thomas Luu, Heather Roberson, Morris F Maduro

Abstract read
In one paragraph

Article in Developmental biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Evolutionary Change in Gut Specification inJournal of developmental biology · 2023
    Review
  5. The long isoform of themicroPublication biology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. A Strategy To Isolate Modifiers ofG3 (Bethesda, Md.) · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Melissa OwraghiDepartment of Biology, University of California, 2121A Genomics Building, Riverside, Riverside, CA 92521, USA.
Gina Broitman-Maduro
Thomas Luu
Heather Roberson
Morris F Maduro
University of California, Riverside · US

Funding

UC Riverside MARC U* Star Undergraduate Research ProgramT34GM062756 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI MARTINEZ, ERNEST · 2001 to 2022
$8.7M
Specification of embryonic C. elegans mesoderm by a T-box factorR03HD054589 · NICHD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI MADURO, MORRIS F · 2007 to 2008
$149k
NICHD NIH HHS 1R03HD054589-01NICHD NIH HHS R03 HD054589NIGMS NIH HHS T34 GM062756NIGMS NIH HHS T34GM062756
6 · The paper itself

Abstract

In C. elegans the 4-cell stage blastomere EMS is an endomesodermal precursor. Its anterior daughter, MS, makes primarily mesodermal cells, while its posterior daughter E generates the entire intestine. The gene regulatory network underlying specification of MS and E has been the subject of study for more than 15 years. A key component of the specification of the two cells is the involvement of the Wnt/beta-catenin asymmetry pathway, which through its nuclear effector POP-1, specifies MS and E as different from each other. Loss of pop-1 function results in the mis-specification of MS as an E-like cell, because POP-1 directly represses the end-1 and end-3 genes in MS, which would otherwise promote an endoderm fate. A long-standing question has been whether POP-1 plays a role in specifying MS fate beyond repression of endoderm fate. This question has been difficult to ask because the only chromosomal lesions that remove both end-1 and end-3 are large deletions removing hundreds of genes. Here, we report the construction of bona fide end-1 end-3 double mutants. In embryos lacking activity of end-1, end-3 and pop-1 together, we find that MS fate is partially restored, while E expresses early markers of MS fate and adopts characteristics of both MS and C. Our results suggest that POP-1 is not critical for MS specification beyond repression of endoderm specification, and reveal that Wnt-modified POP-1 and END-1/3 further reinforce E specification by repressing MS fate in E. By comparison, a previous work suggested that in the related nematode C. briggsae, Cb-POP-1 is not required to repress endoderm specification in MS, in direct contrast with Ce-POP-1, but is critical for repression of MS fate in E. The findings reported here shed new light on the flexibility of combinatorial control mechanisms in endomesoderm specification in Caenorhabditis.

Indexed as

Gene Regulatory NetworksAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansCaenorhabditis elegans ProteinsDNA-Binding ProteinsEmbryo, NonmammalianEndodermGene Expression Regulation, DevelopmentalGenes, HelminthHigh Mobility Group ProteinsMesodermModels, BiologicalMutationTranscription FactorsWnt ProteinsCaenorhabditis elegans ProteinsDNA-Binding ProteinsHigh Mobility Group Proteinspop-1 protein, C elegansTranscription FactorsWnt Proteins

Identifiers

PMID19818340
PMCPMC2854320
OpenAlexW2043713333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.